References
- AllardSSainatiSMRoth-SchechterBF1999Coadministration of short-term zolpidem with sertraline in healthy womenJ Clin Pharmacol391849111563412
- Ambien Prescribing Information2005Ambien (zolpidem tartrate)New York, NYSanofi-Synthelabo10
- Ambien CR Prescribing Information2007Ambien CR (zolpidem tartrate extended release)Bridgewater, NJSanofi-Aventis4
- BessetATaftiMVilleminE1995Effects of zolpidem on the architecture and cyclical structure of sleep in poor sleepersDrugs Exp Clin Res2116198529530
- BlinOMicallefJAudebertC2006A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteersJ Clin Psychopharmacol26284916702893
- DroverDR2004Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem, and zopicoloneClin Pharmacokinet432273815005637
- ElkoCJBurgessJLRoberstonWO1998Zolpidem-associated hallucinations and serotonin reuptake inhibition: A possible interactionJ Tox Clin Tox36195203
- [FDA] United States Food and Drug Administration2007FDA requests label changes for all sleep disorder drug products [online]Accessed 2 July 2007 URL: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01587.html
- GreenblattDJLegangneuxEHartmatzJS2007Dynamics and kinetics of a modified-release formulation of zolpidem: Comparison with immediate-release standard zolpidem and placeboJ Clin Pharmacol4614698017101746
- GreenblattDJvon MoltkeLLHarmatzJS1998Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, fluconazoleClin Pharmacol Ther64661719871431
- HindmarchILegangneuxEStanleyN2006A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteersBr J Clin Pharmacol625384517061961
- KupferDJReynoldsCF1997Current concepts: Management of insomniaN Engl J Med33634169011788
- LegerDGuilleminaultCBaderG2002Medical and socio-professional impact of insomniaSleep25625912224841
- MartinSAAikensJEChervinRD2004Toward cost-effectiveness analysis in the diagnosis and treatment of insomniaSleep Med Rev8637215062211
- MorgenthalerTISilberMH2002Amnestic sleep-related eating disorder associated with zolpidemSleep Med3323714592194
- National Sleep Foundation2005Can’t sleep?Learn about insomnia [on-line]Accessed 10 November 2005 URL: http://www.sleepfoundation.org/sleeplibrary/index.php?secid=&id=58
- RothTRoehrsTVogelG1995Zolpidem in the treatment of transient insomnia: A double-blind, randomized comparison with placeboSleep18246517618022
- RothTSoubraneCTiteuxL2006Efficacy and safety of zolpidem-MR: A double-blind, placebo-controlled study in adults with primary insomniaSleep Med739740616815744
- SalvaPCostaJ1995Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implicationsClin Pharmacokinet29142538521677
- ScharfMBRothTVogelGW1994A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomniaJ Clin Psychiatry5519298071269
- StollerMK1994Economic effects of insomniaClin Ther16873977859246
- TonerLCTsambirasBMCatalanoG2000Central nervous system side effects associated with zolpidem treatmentClin Neuropharmacol2354810682233
- VillikkaKKivistoKTLurrilaH1997Rifampin reduces plasma concentrations and effects of zolpidemClin Pharmacol Ther62629349433391
- WalshJK2004Clinical and socioeconomic correlates of insomniaJ Clin Psychiatry65Suppl 813915153063
- WalshJKEngelhardtCL1999The direct economic costs of insomnia in the United States for 1995Sleep22Suppl 2S3869310394612
- WeinlingEMcDougallSAndreF2006Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenanceFundamental Clin Pharmacol20397403